VIP for Neuropathy: Evidence-Graded Look at Immune and Autonomic Layers
What's breaking down
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
Why VIP might help you
- Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.
How these fit together
Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.
- VIP → immune / autonomic
What the evidence actually shows
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 5
- Claims tagged human evidence: 2
- Claims tagged preclinical (animal/lab): 3
- Claims tagged anecdotal: 0
- Reddit posts catalogued: 2
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 7
Quantified confidence (this ledger): 0.49 / 1.00 — low–moderate — mostly preclinical
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
Distinct VIP and PACAP Functions in the Distal Nerve Stump During Peripheral Nerve Regeneration (source s1)
2019 mouse and rat study on VIP effects on Schwann cells and nerve explants post-injury.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Vasoactive Intestinal Peptide and Nerve Regeneration (source s2)
Rat study examining VIP changes after nerve injury.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide... (source s3)
Rat neuron culture study showing VIP protective effects.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide... (source s4)
2025 human study measuring VIP in MS patients.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
A Clinical Approach for the Use of VIP Axis in Inflammatory ... (source s7)
2019 review on VIP in inflammatory conditions.
Evidence type: Published research.
What people say on Reddit
Neuropathy after BEP x 3? — Reddit, r/testicularcancer (source s5)
Reddit discussion of chemo-related neuropathy.
Vasoactive Intestinal Peptide (VIP) Peptide: uses and ... — Reddit, r/healthwithjessicalana (source s6)
General discussion of VIP peptide functions.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Evidence ledger 5 · tier-ranked · API
Ask this article · 8 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.